Good Manufacturing Practices — Glossary · Global Certificate Course in Pharmaceutical Quality Assurance and Control

Active Pharmaceutical Ingredient (API) #

Active Pharmaceutical Ingredient (API)

Related terms #

excipient, bulk drug, raw material. The API is the chemically active component that produces the intended therapeutic effect in a drug product. In GMP, APIs must be sourced from qualified suppliers, characterized for identity, purity, and potency, and stored under controlled conditions to prevent degradation. For example, ibuprofen as the API in a tablet must meet specifications for assay (typically 95‑105 %). Practical application includes batch record review where the API lot number, certificate of analysis (CoA), and storage temperature are documented. Challenges arise when API variability leads to out‑of‑specification (OOS) results, requiring investigation of supplier change, stability, and impact on product release.

Batch Record #

Batch Record

Related terms #

manufacturing record, documentation, traceability. A batch record is the complete, contemporaneous documentation of all manufacturing steps for a specific batch, from raw material receipt through final product release. It includes equipment logs, process parameters, in‑process test results, and deviations. In GMP, the batch record must be reviewed, approved, and retained for the required period (often 5 years). Example: A sterile injectable batch record will capture sterilization cycle parameters, aseptic technique checks, and environmental monitoring data. The main challenge is maintaining accuracy without retroactive entries; electronic batch records (EBR) help but require robust validation and access controls.

Change Control #

Change Control

Related terms #

CAPA, deviation, validation. Change control is the formal process for evaluating, approving, and documenting any modification to processes, equipment, materials, or documentation that could affect product quality. It ensures that changes are assessed for risk, tested if necessary, and communicated to relevant stakeholders. For instance, switching a filtration membrane from 0.2 Μm to 0.45 Μm requires a change control to assess impact on sterility assurance. Practical application includes creating a change request, performing a risk assessment (e.G., FMEA), and updating SOPs. Challenges include balancing timely implementation with thorough risk evaluation and avoiding “change fatigue” among staff.

Cleaning Validation #

Cleaning Validation

Related terms #

residue, cleaning SOP, acceptance criteria. Cleaning validation demonstrates that equipment, containers, and surfaces are cleaned to a predetermined level, preventing cross‑contamination. It involves establishing analytical methods (e.G., Swab, rinse) to detect residual API or cleaning agents, setting acceptance criteria (e.G., < 10 Ppm), and conducting worst‑case studies. Example: A tablet‑press line cleaned after a high‑potency API run must show residues below the detection limit. Practical application includes routine monitoring and re‑validation when product changes occur. Challenges include detecting low‑level residues, method sensitivity, and ensuring consistency across multiple cleaning cycles.

Closed System #

Closed System

Related terms #

aseptic processing, containment, barrier technology. A closed system is a manufacturing environment where the product is never exposed to the ambient atmosphere, minimizing contamination risk. It typically includes isolators, glove boxes, and sealed conveyors. For sterile lyophilized products, a closed system prevents microbial ingress during fill and seal. Practical application involves validating the integrity of the barrier (e.G., Pressure decay testing) and training personnel on proper use. Challenges include equipment maintenance, ensuring proper gowning, and managing system alarms that could halt production.

Commissioning #

Commissioning

Related terms #

qualification, installation, start‑up. Commissioning is the set of activities performed after equipment installation to verify that all utilities, components, and subsystems are installed correctly and function as intended. It precedes qualification (IQ, OQ, PQ). Example: Commissioning a HVAC system includes checking airflow, temperature, and humidity control before proceeding to installation qualification. Practical application requires detailed checklists and documented evidence. Challenges involve coordinating multiple contractors, resolving installation defects, and ensuring that commissioning data are retained for future audits.

Contamination Control #

Contamination Control

Related terms #

GMP, cleanroom, microbial monitoring. Contamination control encompasses all strategies to prevent, detect, and control particulate and microbial contamination in manufacturing areas. This includes facility design, air filtration (HEPA), gowning protocols, personnel flow, and routine environmental monitoring. For a sterile ophthalmic solution, contamination control ensures that viable particle counts remain below defined limits (e.G., < 1 CFU per 100 L). Practical application includes establishing action and investigation limits, conducting trend analysis, and implementing corrective actions. Challenges include maintaining compliance in high‑traffic areas, dealing with unexpected spikes, and integrating new technologies without compromising control.

Corrective and Preventive Action (CAPA) #

Corrective and Preventive Action (CAPA)

Related terms #

deviation, root cause analysis, quality improvement. CAPA is a systematic approach to investigate non‑conformances, implement corrective measures, and prevent recurrence. It starts with identification of a deviation, followed by root cause analysis (e.G., 5 Whys, fishbone diagram), corrective action implementation, effectiveness verification, and documentation. Example: A recurring OOS assay result triggers a CAPA that identifies a worn filter as the root cause, leading to filter replacement and revised SOP. Practical application includes tracking CAPA status in a quality management system. Challenges involve timely closure, ensuring actions are truly preventive, and avoiding “paper‑only” solutions.

Critical Process Parameter (CPP) #

Critical Process Parameter (CPP)

Related terms #

critical quality attribute (CQA), process control, PAT. CPPs are the key variables within a manufacturing process that have a direct impact on product quality and must be monitored and controlled. For a lyophilization cycle, CPPs may include shelf temperature, chamber pressure, and drying time. Establishing CPPs involves risk assessment and linking them to CQAs. Practical application includes real‑time monitoring using Process Analytical Technology (PAT) tools and establishing control limits. Challenges include defining appropriate limits, dealing with process variability, and ensuring that monitoring does not interfere with the process.

Deviation #

Deviation

Related terms #

non‑conformance, investigation, CAPA. A deviation is any departure from approved procedures, specifications, or standard operating procedures (SOPs) that may affect product quality. Deviations must be recorded, investigated, and, if needed, escalated to CAPA. Example: A temperature excursion during storage of a bulk intermediate constitutes a deviation. Practical application includes immediate deviation reporting, impact assessment, and corrective actions such as re‑processing or product hold. Challenges include differentiating minor from major deviations, ensuring timely investigation, and maintaining a culture where staff feel comfortable reporting.

Environmental Monitoring (EM) #

Environmental Monitoring (EM)

Related terms #

ISO class, viable and non‑viable particles, trend analysis. EM is the systematic sampling and testing of air, surfaces, and personnel to assess the cleanliness of manufacturing areas. It includes measuring particulate counts (non‑viable) and microbial loads (viable). For a Grade A aseptic zone, EM may require settle plates, active air samplers, and personnel glove prints. Practical application involves defining sampling locations, frequencies, and acceptance criteria aligned with USP <797> or EU GMP Annex 1. Challenges include interpreting data trends, responding to out‑of‑specification results, and integrating EM data into risk‑based decision making.

Equipment Qualification (EQ) #

Equipment Qualification (EQ)

Related terms #

IQ, OQ, PQ, validation, performance qualification. Equipment qualification verifies that equipment operates as intended and consistently produces results within predetermined limits. It is divided into Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ). Example: A tablet press is qualified by confirming installation (IQ), testing operational parameters (OQ), and producing a full‑scale batch to demonstrate consistent tablet weight and hardness (PQ). Practical application includes documented protocols, test results, and sign‑off by qualified personnel. Challenges involve maintaining qualification status after modifications, dealing with equipment aging, and ensuring that qualification data are readily available for audits.

Excipient #

Excipient

Related terms #

API, binder, filler, diluent. Excipients are inactive substances added to a drug product to aid in formulation, manufacturing, or stability. They include binders, lubricants, disintegrants, and preservatives. For a solid oral dosage form, microcrystalline cellulose may serve as a filler, while magnesium stearate acts as a lubricant. Practical application entails supplier qualification, testing for identity and impurity levels, and ensuring compatibility with the API. Challenges include excipient‑API interactions leading to degradation, variability in excipient quality, and regulatory scrutiny of novel excipients.

Facility Design #

Facility Design

Related terms #

cleanroom classification, HVAC, flow control. Facility design is the planning and construction of manufacturing spaces to meet GMP requirements, including appropriate cleanroom classification, material and personnel flow, and environmental controls. For a sterile product line, the design must provide separate zones for raw material receipt, formulation, filling, and packaging with controlled air pressure differentials. Practical application includes using ISO 14644‑1 standards, conducting CFD modeling for airflow, and validating utilities. Challenges involve retrofitting existing facilities, cost constraints, and ensuring design flexibility for future product changes.

Good Documentation Practices (GDP) #

Good Documentation Practices (GDP)

Related terms #

ALCOA, record integrity, audit trail. GDP defines the principles for creating, handling, and storing documents to ensure data integrity, traceability, and compliance. Core principles include Attributable, Legible, Contemporaneous, Original, and Accurate (ALCOA). Example: A laboratory notebook entry must be dated, signed, and recorded at the time of observation. Practical application includes training staff on proper form completion, restricting document alteration, and implementing electronic signatures. Challenges include preventing “copy‑and‑paste” errors, managing document version control, and ensuring that electronic systems meet 21 CFR Part 11 requirements.

Hazard Analysis and Critical Control Points (HACCP) #

Hazard Analysis and Critical Control Points (HACCP)

Related terms #

risk assessment, CCP, preventive controls. Although originally developed for food safety, HACCP principles are applied in pharmaceutical GMP to identify hazards, determine critical control points, and establish monitoring procedures. For a sterile manufacturing process, a CCP could be the sterilization cycle, where temperature and time are monitored. Practical application includes creating a HACCP plan, defining limits, corrective actions, and verification activities. Challenges involve integrating HACCP with existing GMP quality systems, ensuring staff understanding, and maintaining documentation for regulatory inspections.

In‑Process Control (IPC) #

In‑Process Control (IPC)

Related terms #

process monitoring, CPP, real‑time release. IPC refers to the testing and monitoring performed during manufacturing to ensure that the process remains within predefined limits, thereby guaranteeing product quality. Examples include checking blend uniformity during granulation, monitoring pH during fermentation, or measuring tablet weight during compression. Practical application includes establishing acceptance criteria, sampling plans, and corrective actions if parameters drift. Challenges include balancing the frequency of testing with production efficiency, interpreting data in real time, and integrating IPC results into final product release decisions.

Installation Qualification (IQ) #

Installation Qualification (IQ)

Related terms #

equipment qualification, OQ, PQ. IQ verifies that equipment, utilities, and software are installed according to design specifications, with proper documentation, utilities, and safety features. It includes checks such as serial numbers, calibration certificates, and utility connections. Example: Verifying that a water‑for‑injection (WFI) system is properly connected to a validated purification train. Practical application involves completing an IQ protocol, signing off, and archiving the records. Challenges include ensuring that all components are accounted for, dealing with changes after installation, and maintaining a clear audit trail.

Integrated Quality Management System (QMS) #

Integrated Quality Management System (QMS)

Related terms #

ISO 9001, CAPA, change control. An integrated QMS combines all quality-related processes—document control, training, deviation management, supplier qualification, and continuous improvement—into a cohesive framework. It aligns with regulatory expectations (e.G., ICH Q10) and supports risk‑based decision making. Practical application includes using a centralized electronic QMS platform that links CAPA, audit findings, and change control. Challenges involve ensuring cross‑functional communication, avoiding siloed data, and keeping the system up‑to‑date with evolving regulations.

International Council for Harmonisation (ICH) #

International Council for Harmonisation (ICH)

Related terms #

Q1–Q12, GMP guidelines, regulatory convergence. ICH is a global initiative that develops harmonized guidelines for pharmaceutical development, registration, and post‑approval. Key GMP‑related guidelines include Q7 (GMP for APIs), Q9 (Quality Risk Management), Q10 (Pharmaceutical Quality System), and Q12 (Technical and Regulatory Considerations for Lifecycle Management). Practical application involves referencing ICH guidelines when establishing SOPs, performing risk assessments, and preparing regulatory submissions. Challenges include interpreting guidance across regions, updating processes when new ICH revisions are released, and training staff on global expectations.

ISO Class #

ISO Class

Related terms #

cleanroom classification, ISO 14644‑1, particulate limits. ISO class designates the cleanliness level of a controlled environment based on the concentration of airborne particles. For example, ISO Class 5 permits no more than 3520 particles ≥ 0.5 Μm per cubic meter. In GMP, ISO classifications are mapped to USP/European cleanroom grades to define appropriate controls. Practical application includes routine monitoring, classification verification, and corrective actions when particle counts exceed limits. Challenges involve maintaining classification during personnel movement, equipment changes, and high‑throughput operations.

Lot Release #

Lot Release

Related terms #

certificate of analysis (CoA), final product testing, release criteria. Lot release is the formal authorization, usually by the quality assurance department, that a manufactured batch meets all specifications and is fit for distribution. It requires review of analytical test results, stability data, and compliance with GMP documentation. Example: A vaccine lot is released after confirming potency, sterility, and endotoxin limits. Practical application includes generating a CoA, signing the release, and updating inventory systems. Challenges include handling delayed test results, managing hold releases under pressure, and ensuring that any post‑release changes are documented.

Material Traceability #

Material Traceability

Related terms #

batch record, serial number, genealogy. Material traceability ensures that every component used in a product can be traced back to its source and forward to the final product. This includes raw material lot numbers, intermediate IDs, and final batch numbers. Practical application involves recording material receipts, linking them to manufacturing steps, and maintaining a genealogy matrix. Example: In case of a recall, traceability enables rapid identification of affected batches. Challenges include managing large data sets, integrating multiple ERP systems, and ensuring that manual entries are accurate.

Microbial Limit Testing (MLT) #

Microbial Limit Testing (MLT)

Related terms #

sterility test, USP <71>, bioburden. MLT assesses the microbial content of non‑sterile products and confirms sterility of sterile products. It includes tests for total aerobic microbial count, yeast and mold, and specific pathogens. For an oral suspension, MLT may require a bioburden test with a limit of ≤ 10⁴ CFU/mL. Practical application involves sample preparation, incubation, and enumeration according to pharmacopeial methods. Challenges include detecting slow‑growing organisms, ensuring laboratory asepsis, and interpreting results for borderline cases.

Operational Qualification (OQ) #

Operational Qualification (OQ)

Related terms #

equipment qualification, IQ, PQ. OQ confirms that equipment operates within defined limits under simulated worst‑case conditions. It includes testing alarms, interlocks, temperature controls, and software functions. Example: Verifying that a lyophilizer’s temperature sensors respond accurately across 0‑−80 °C. Practical application requires detailed OQ protocols, data collection, and sign‑off. Challenges include replicating real‑process loads, managing equipment downtime, and documenting all test results for regulatory scrutiny.

Process Analytical Technology (PAT) #

Process Analytical Technology (PAT)

Related terms #

real‑time monitoring, CPP, QbD. PAT is a system for designing, analyzing, and controlling manufacturing processes through real‑time measurements of critical quality and performance attributes. It utilizes sensors (e.G., NIR, Raman), data analytics, and feedback loops. For a continuous manufacturing line, PAT may monitor API concentration in real time, enabling immediate adjustments. Practical application includes developing multivariate models, validating sensor performance, and integrating PAT data into the batch record. Challenges involve sensor calibration, data management, and regulatory acceptance of novel PAT approaches.

Quality Risk Management (QRM) #

Quality Risk Management (QRM)

Related terms #

ICH Q9, FMEA, risk matrix. QRM is a systematic process for assessing, controlling, communicating, and reviewing risks throughout a product’s lifecycle. Tools include Failure Mode Effects Analysis (FMEA), risk ranking, and decision trees. Example: Assessing the risk of a temperature excursion during storage of a heat‑sensitive API. Practical application involves documenting risk assessments, implementing mitigations, and reviewing effectiveness. Challenges include quantifying intangible risks, avoiding overly conservative approaches that impede innovation, and ensuring risk assessments are proportionate to the product’s complexity.

Qualified Person (QP) #

Qualified Person (QP)

Related terms #

EU GMP, product release, regulatory authority. In the EU, the QP is a designated professional authorized to certify that each batch of medicinal product complies with the marketing authorization and GMP. The QP must possess appropriate scientific qualifications and experience. Practical application includes reviewing batch records, test results, and deviations before signing the release certificate. Challenges involve maintaining competency, handling multi‑national responsibilities, and ensuring that QP decisions align with evolving regulatory expectations.

Regulatory Inspection #

Regulatory Inspection

Related terms #

GMP audit, FDA, EMA, compliance. A regulatory inspection is an official review by authorities (e.G., FDA, EMA, MHRA) to assess compliance with GMP, product quality, and documentation. Inspectors evaluate facilities, records, personnel training, and product history. Practical application includes preparing for inspections through mock audits, maintaining an inspection readiness file, and promptly addressing findings. Challenges include managing resource constraints during inspection periods, interpreting inspection observations, and implementing corrective actions without disrupting production.

Release Specification #

Release Specification

Related terms #

test method, acceptance criteria, CoA. Release specifications define the quantitative limits for each quality attribute that a product must meet before it can be released. They are derived from development data, stability studies, and regulatory requirements. Example: A tablet must have assay 95‑105 %, dissolution ≥ 80 % in 30 minutes, and hardness 5‑8 kp. Practical application involves establishing specifications in the master formula, performing final product testing, and documenting compliance on the CoA. Challenges include adjusting specifications for new formulations, handling borderline OOS results, and ensuring that specifications are not overly restrictive.

Sterility Assurance Level (SAL) #

Sterility Assurance Level (SAL)

Related terms #

sterility test, aseptic processing, risk assessment. SAL is the probability of a viable microorganism surviving in a sterile product. An SAL of 10⁻⁶ (one in a million) is the standard for most sterile pharmaceuticals. Achieving this level relies on validated aseptic processes, environmental monitoring, and sterilization cycles. Practical application includes calculating SAL based on process data, validating sterilization parameters, and performing sterility testing per USP <71>. Challenges involve verifying that the theoretical SAL matches real‑world performance, especially for complex biologics or high‑potency products.

Supply Chain Management (SCM) #

Supply Chain Management (SCM)

Related terms #

vendor qualification, traceability, risk mitigation. SCM in GMP covers the planning, execution, and control of material flow from raw material suppliers to the finished product distribution. It includes supplier qualification, qualification of logistics providers, and inventory control. Practical application involves establishing supplier audits, monitoring performance metrics, and implementing contingency plans for shortages. Challenges include geopolitical disruptions, raw material variability, and ensuring that all supply chain participants adhere to GMP standards.

Temperature Controlled Storage #

Temperature Controlled Storage

Related terms #

cold chain, stability, monitoring. Temperature controlled storage ensures that products or intermediates are kept within defined temperature ranges (e.G., 2‑8 °C for vaccines) to maintain stability and potency. Monitoring includes continuous data logging, alarm systems, and periodic verification. Practical application includes defining storage zones, validating refrigeration units, and conducting trend analysis. Challenges involve power failures, temperature excursions during transport, and reconciling data from multiple monitoring devices.

Validation #

Validation

Related terms #

IQ, OQ, PQ, lifecycle, performance qualification. Validation is the documented evidence that a process, method, or system consistently produces a product meeting its predetermined specifications and quality attributes. It follows a defined lifecycle: Design, qualification, performance qualification, and ongoing monitoring. Example: Validating a tablet coating process includes establishing coating uniformity, drying time, and visual appearance. Practical application requires protocol development, data collection, statistical analysis, and final report approval. Challenges include allocating resources for extensive testing, managing changes post‑validation, and ensuring that validation remains current with evolving technology.

Verification #

Verification

Related terms #

validation, compliance, audit. Verification is the act of confirming that a specific requirement has been fulfilled, often as part of a larger validation effort. It may involve checking that a calibrated instrument meets its specification or that a standard operating procedure (SOP) is correctly implemented. Practical application includes performing periodic reviews, re‑qualification after equipment modification, and documenting results. Challenges include ensuring that verification activities are not overlooked, maintaining traceability, and differentiating verification from routine maintenance.

Vigilance #

Vigilance

Related terms #

pharmacovigilance, post‑marketing surveillance, adverse event. Vigilance refers to the systematic monitoring of a pharmaceutical product after it has been released to the market, focusing on safety, efficacy, and quality issues. It includes collection, assessment, and reporting of adverse events, product complaints, and field investigations. Practical application involves establishing a pharmacovigilance system, training staff on reporting procedures, and communicating findings to regulatory authorities. Challenges include handling large volumes of data, ensuring timely reporting, and integrating vigilance findings into CAPA and quality improvement cycles.

Water for Injection (WFI) #

Water for Injection (WFI)

Related terms #

purified water, USP <797>, critical utility. WFI is a high‑purity water used for parenteral preparations, meeting stringent microbial and endotoxin limits (e.G., ≤ 0.25 EU/mL). It is produced via distillation, reverse osmosis, or a combination of purification steps, followed by stringent storage and distribution controls. Practical application includes continuous monitoring of conductivity, temperature, and microbial load, as well as regular validation of the WFI system. Challenges involve preventing biofilm formation, maintaining system integrity during shutdowns, and ensuring compliance with evolving pharmacopeial standards.

Yield #

Yield

Related terms #

process efficiency, batch size, loss. Yield is the ratio of the amount of product obtained to the theoretical amount based on input material, expressed as a percentage. High yield indicates efficient use of raw materials and minimal waste. For a fermentation process, a 85 % yield might be acceptable, while a 95 % yield may be required for a high‑value API. Practical application includes monitoring yield during each batch, investigating deviations that cause low yield, and implementing process improvements. Challenges include balancing yield with product quality, addressing variability in raw material quality, and ensuring that yield calculations are accurate and auditable.

Yield Loss #

Yield Loss

Related terms #

process deviation, scrap, rework. Yield loss denotes the portion of material that does not meet specifications and must be discarded or re‑processed. Causes include equipment malfunction, operator error, or contamination. For example, a tablet press mis‑alignment may produce off‑weight tablets, resulting in a 3 % yield loss. Practical application involves root‑cause analysis, corrective actions to restore target yield, and documentation in the batch record. Challenges include quantifying loss accurately, minimizing economic impact, and preventing recurrence through robust process controls.